DAA928 |
Sex hormone binding globulin levels increase |
— |
plasma |
Human |
|
DAA933 |
No changes in erythroid and myeloid progenitor cells evident |
— |
myeloid progenitor cell |
Human |
|
DAA844 |
Postprandial serum bile acids decrease |
— |
alimentary system |
Human |
|
DAA834 |
Gastric secretions diminish |
— |
alimentary system |
Human |
|
DAA826 |
Weaker digestive tract muscle contractions |
— |
alimentary system, smooth muscle |
Human |
|
DAA827 |
Slowing down of peristaltic motion in alimentary canal |
— |
alimentary system |
Human |
|
DAA830 |
Diminishing of glandular secretions |
— |
alimentary system |
Human |
|
DAA835 |
D-xylose absorption decreases |
— |
alimentary system |
Human |
|
DAA858 |
Enteric neuron loss |
— |
alimentary system |
Human |
|
DAA991 |
Decreased function of epithelial barriers |
— |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
|
DAA2058 |
Mosaic abnormalities increase |
— |
blood, oral cavity |
Human |
|
DAA831 |
Mouth becomes drier |
— |
salivary gland |
Human |
|
DAA833 |
Increase in adverse effects on salivary gland by anticholinergics |
— |
salivary gland |
Human |
|
DAA832 |
Decrease in number of acinar cells |
— |
salivary gland |
Human |
|
DAA825 |
Dental wear and tear |
— |
tooth |
Human |
|
DAA991 |
Decreased function of epithelial barriers |
— |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
|
DAA850 |
Dysphagia incidence increases |
— |
oropharynx, oesophagus |
Human |
|
DAA852 |
Deficiencies in generating secondary peristaltic contractions |
— |
oropharynx, oesophagus |
Human |
|
DAA851 |
Peristaltic amplitude is diminished |
— |
oropharynx, oesophagus |
Human |
|
DAA828 |
Increase in amplitude and duration of peristaltic pressure wave in hypopharyngeal sphincter |
— |
hypopharynx |
Human |
|
DAA857 |
Myenteric plexus neuron number decreases |
— |
oesophagus, stomach, intestine |
Human |
|
DAA829 |
Decrease in amplitude of peristaltic pressure wave in upper esophogeal sphincter |
— |
oesophagus |
Human |
|
DAA991 |
Decreased function of epithelial barriers |
— |
lung, oral cavity, pharynx, oesophagus, stomach, intestine, epidermis |
Human |
|
DAA853 |
Esophageal acid contact time increased |
— |
oesophagus |
Human |
|
DAA850 |
Dysphagia incidence increases |
— |
oropharynx, oesophagus |
Human |
|